financetom
Business
financetom
/
Business
/
Travelers Companies Insider Sold Shares Worth $6,419,364, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Travelers Companies Insider Sold Shares Worth $6,419,364, According to a Recent SEC Filing
May 30, 2025 2:37 PM

05:26 PM EDT, 05/30/2025 (MT Newswires) -- Avrohom J. Kess, Vice Chmn & Chief Legal Officer, on May 29, 2025, sold 23,434 shares in Travelers Companies ( TRV ) for $6,419,364. Following the Form 4 filing with the SEC, Kess has control over a total of 48,387 shares of the company, with 48,387 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/86312/000112760225016069/xslF345X05/form4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Pantages Capital Acquisition Announces Business Combination With MacMines Austasia
BRIEF-Pantages Capital Acquisition Announces Business Combination With MacMines Austasia
Nov 19, 2025
Nov 19 (Reuters) - Pantages Capital Acquisition Corp ( PGAC ) : * PANTAGES CAPITAL ACQUISITION CORPORATION ANNOUNCES BUSINESS COMBINATION WITH MACMINES AUSTASIA PTY LTD. * PANTAGES CAPITAL ACQUISITION CORP ( PGAC ) -TRANSACTION VALUES TARGET AT USD$180 MILLION * PANTAGES CAPITAL ACQUISITION CORP ( PGAC ): UPON CLOSING OF DEAL, SHARES OF COMBINED COMPANY ARE EXPECTED TO TRADE ON...
Lightbridge Begins Testing Enriched Uranium-Zirconium Alloy Samples
Lightbridge Begins Testing Enriched Uranium-Zirconium Alloy Samples
Nov 19, 2025
08:24 AM EST, 11/19/2025 (MT Newswires) -- Lightbridge ( LTBR ) said Wednesday that it has begun irradiation testing of its enriched uranium-zirconium alloy fuel material samples. The company said the testing is intended to collect key material performance data for its Lightbridge ( LTBR ) fuel design. The tests are being conducted at the Advanced Test Reactor in Arco,...
Scynexis Transfers Brexafemme New Drug Application to GSK
Scynexis Transfers Brexafemme New Drug Application to GSK
Nov 19, 2025
08:24 AM EST, 11/19/2025 (MT Newswires) -- Scynexis ( SCYX ) said Wednesday it has completed the transfer of the new drug application for Brexafemme, or ibrexafungerp, to GSK (GSK). The transfer allows GSK to begin working with the US Food and Drug Administration on a plan to relaunch Brexafemme for vulvovaginal candidiasis and refractory vulvovaginal candidiasis in the US,...
EyePoint Gets Positive Recommendation for Wet AMD Trials From Safety Committee
EyePoint Gets Positive Recommendation for Wet AMD Trials From Safety Committee
Nov 19, 2025
08:29 AM EST, 11/19/2025 (MT Newswires) -- EyePoint Pharmaceuticals ( EYPT ) said Wednesday that an independent Data Safety Monitoring Committee has recommended that its ongoing pivotal phase 3 program evaluating Duravyu for the treatment of wet age-related macular degeneration continue as planned without any modifications to the protocol. Topline data from the trials is expected starting in mid-2026, the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved